Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic myeloid leukemia: Second-line drugs of choice.
Gambacorti-Passerini C, Aroldi A, Cordani N, Piazza R. Gambacorti-Passerini C, et al. Among authors: cordani n. Am J Hematol. 2016 Jan;91(1):67-75. doi: 10.1002/ajh.24247. Am J Hematol. 2016. PMID: 26588811 Free article. Review.
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib.
Sharma GG, Cortinovis D, Agustoni F, Arosio G, Villa M, Cordani N, Bidoli P, Bisson WH, Pagni F, Piazza R, Gambacorti-Passerini C, Mologni L. Sharma GG, et al. Among authors: cordani n. J Thorac Oncol. 2019 Nov;14(11):e257-e259. doi: 10.1016/j.jtho.2019.06.028. J Thorac Oncol. 2019. PMID: 31668326 Free article. No abstract available.
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.
Ilari A, Cogliati V, Sherif N, Grassilli E, Ramazzotti D, Cordani N, Cazzaniga G, Di Bella C, Lavitrano M, Cazzaniga ME, Cerrito MG. Ilari A, et al. Among authors: cordani n. Biomedicines. 2024 Jan 25;12(2):272. doi: 10.3390/biomedicines12020272. Biomedicines. 2024. PMID: 38397874 Free PMC article.
Metronomic Chemotherapy.
Cazzaniga ME, Cordani N, Capici S, Cogliati V, Riva F, Cerrito MG. Cazzaniga ME, et al. Among authors: cordani n. Cancers (Basel). 2021 May 6;13(9):2236. doi: 10.3390/cancers13092236. Cancers (Basel). 2021. PMID: 34066606 Free PMC article. Review.
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.
Cortinovis DL, Colonese F, Abbate MI, Sala L, Meazza Prina M, Cordani N, Sala E, Canova S. Cortinovis DL, et al. Among authors: cordani n. Front Med (Lausanne). 2022 Dec 1;9:989405. doi: 10.3389/fmed.2022.989405. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530878 Free PMC article. Review.
27 results